These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22026449)

  • 21. Bile salts differentially sensitize esophageal squamous cells to CD95 (Fas/Apo-1 receptor) mediated apoptosis.
    Naran S; Abrams P; de Oliveira PQ; Hughes SJ
    J Surg Res; 2011 Dec; 171(2):504-9. PubMed ID: 20934723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended lifespan of Barrett's esophagus epithelium transduced with the human telomerase catalytic subunit: a useful in vitro model.
    Palanca-Wessels MC; Klingelhutz A; Reid BJ; Norwood TH; Opheim KE; Paulson TG; Feng Z; Rabinovitch PS
    Carcinogenesis; 2003 Jul; 24(7):1183-90. PubMed ID: 12807723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in mitochondrial stability during the progression of the Barrett's esophagus disease sequence.
    O'Farrell NJ; Feighery R; Picardo SL; Lynam-Lennon N; Biniecka M; McGarrigle SA; Phelan JJ; MacCarthy F; O'Toole D; Fox EJ; Ravi N; Reynolds JV; O'Sullivan J
    BMC Cancer; 2016 Jul; 16():497. PubMed ID: 27431913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 expression in esophageal epithelium before and after photodynamic therapy for Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma.
    Yachimski P; Mino-Kenudson M; Sherwood ME; Puricelli WP; Nishioka NS; Lauwers GY
    Virchows Arch; 2011 Dec; 459(6):581-6. PubMed ID: 22081106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
    Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
    Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profile and cellular localizations of mucin proteins, CK7, and cytoplasmic p27 in Barrett's esophagus and esophageal adenocarcinoma.
    Ozcan HEA; Anuk T; Ozden O
    Adv Med Sci; 2018 Sep; 63(2):296-300. PubMed ID: 29803118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esophageal pepsin and proton pump synthesis in barrett's esophagus and esophageal adenocarcinoma.
    Samuels TL; Altman KW; Gould JC; Kindel T; Bosler M; MacKinnon A; Hagen CE; Johnston N
    Laryngoscope; 2019 Dec; 129(12):2687-2695. PubMed ID: 31046139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker.
    Turner JR; Odze RD; Crum CP; Resnick MB
    Hum Pathol; 1997 Jun; 28(6):740-4. PubMed ID: 9191010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of COX-2, Ki-67, and BCL-2 expression in normal esophageal mucosa, Barrett's esophagus, dysplasia, and adenocarcinoma with postablation mucosa and implications for ablative therapies.
    Lewis CJ; Thrumurthy SG; Pritchard S; Armstrong G; Attwood SE
    Surg Endosc; 2011 Aug; 25(8):2564-9. PubMed ID: 21359892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatty acid synthase expression in Barrett's esophagus: implications for carcinogenesis.
    Ishimura N; Amano Y; Sanchez-Siles AA; Fukuhara H; Takahashi Y; Uno G; Tamagawa Y; Mishima Y; Yuki T; Ishihara S; Kinoshita Y
    J Clin Gastroenterol; 2011 Sep; 45(8):665-72. PubMed ID: 21325951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia.
    Souza RF
    J Gastroenterol; 2017 Jul; 52(7):767-776. PubMed ID: 28451845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
    Jankowski J; Hopwood D; Pringle R; Wormsley KG
    Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T).
    Jaiswal KR; Morales CP; Feagins LA; Gandia KG; Zhang X; Zhang HY; Hormi-Carver K; Shen Y; Elder F; Ramirez RD; Sarosi GA; Spechler SJ; Souza RF
    Dis Esophagus; 2007; 20(3):256-64. PubMed ID: 17509124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sox9 drives columnar differentiation of esophageal squamous epithelium: a possible role in the pathogenesis of Barrett's esophagus.
    Clemons NJ; Wang DH; Croagh D; Tikoo A; Fennell CM; Murone C; Scott AM; Watkins DN; Phillips WA
    Am J Physiol Gastrointest Liver Physiol; 2012 Dec; 303(12):G1335-46. PubMed ID: 23064761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between rate of change in acid exposure along the esophagus and length of Barrett's epithelium.
    Tharalson EF; Martinez SD; Garewal HS; Sampliner RE; Cui H; Pulliam G; Fass R
    Am J Gastroenterol; 2002 Apr; 97(4):851-6. PubMed ID: 12003418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors.
    Konturek PC; Nikiforuk A; Kania J; Raithel M; Hahn EG; Mühldorfer S
    Dig Dis Sci; 2004 Aug; 49(7-8):1075-83. PubMed ID: 15387324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mechanism of acid and bile acid-induced DNA damage involving Na+/H+ exchanger: implication for Barrett's oesophagus.
    Goldman A; Shahidullah M; Goldman D; Khailova L; Watts G; Delamere N; Dvorak K
    Gut; 2010 Dec; 59(12):1606-16. PubMed ID: 20876775
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.